#heart-failure

[ follow ]
#funding

Sweden's Acorai bags 4.2M to advance heart failure management devices

Acorai secures $4.5M funding for its heart failure management device and aims for market launch by 2026.

Dublin-based FIRE1 secures 115M to help patients suffering from chronic diseases - Silicon Canals

FIRE1 secured $120M to advance heart failure management technology through clinical trials and FDA recognition.

Sweden's Acorai bags 4.2M to advance heart failure management devices

Acorai secures $4.5M funding for its heart failure management device and aims for market launch by 2026.

Dublin-based FIRE1 secures 115M to help patients suffering from chronic diseases - Silicon Canals

FIRE1 secured $120M to advance heart failure management technology through clinical trials and FDA recognition.
morefunding
#obesity

Weight-loss drug reduces risk of early death for patients with heart failure, trial finds

Tirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.

Semaglutide leads to greater weight loss in women than men with HF and improves HF symptoms

Semaglutide improves heart failure symptoms, with sex-based differences in weight loss and benefits.

Weight Loss Drug Shows Benefits for Heart Failure - News Center

Semaglutide can reduce heart failure symptoms and hospitalizations in obese patients with HFpEF.

Weight-loss drug reduces risk of early death for patients with heart failure, trial finds

Tirzepatide reduces the risk of death and worsening heart failure in patients with obesity and preserved heart function.

Semaglutide leads to greater weight loss in women than men with HF and improves HF symptoms

Semaglutide improves heart failure symptoms, with sex-based differences in weight loss and benefits.

Weight Loss Drug Shows Benefits for Heart Failure - News Center

Semaglutide can reduce heart failure symptoms and hospitalizations in obese patients with HFpEF.
moreobesity

How a Brooklyn hospital network is addressing disparities in the outer boroughs

Maimonides Medical Center addresses healthcare disparities by providing advanced heart failure treatment with L.V.A.D., enhancing patient quality of life in Brooklyn.
#medical-breakthrough

Breakthrough Titanium Heart Design Successfully Implanted in a Human - Yanko Design

The BiVACOR Total Artificial Heart (TAH) offers a groundbreaking solution for severe heart conditions, suitable for patients ineligible for traditional devices.

Woman Becomes First Person to Receive Both Pig Kidney Transplant and Heart Pump

A groundbreaking procedure involving a genetically modified pig kidney transplant offers hope for patients with both heart and kidney disease.

Breakthrough Titanium Heart Design Successfully Implanted in a Human - Yanko Design

The BiVACOR Total Artificial Heart (TAH) offers a groundbreaking solution for severe heart conditions, suitable for patients ineligible for traditional devices.

Woman Becomes First Person to Receive Both Pig Kidney Transplant and Heart Pump

A groundbreaking procedure involving a genetically modified pig kidney transplant offers hope for patients with both heart and kidney disease.
moremedical-breakthrough

Vaping may increase the risk of heart failure, study suggests

Vaping may significantly increase heart failure risk.
Research indicates vaping linked to heart health impacts.

Covid vaccines cut risk of virus-related heart failure and blood clots, study finds

Covid vaccinations reduce heart failure and blood clot risks
Vaccines by Oxford-AstraZeneca, Pfizer, and Moderna effective

Medical device company Procyrion Closes $57.7 Million Series E Financing Round

Procyrion secures $57.7 million in Series E funding round
Additional $10 million secured from interim financing
[ Load more ]